Translational research moves novel discoveries in basic biological sciences to practical uses in pharmaceutical or clinical settings. The TRG program promotes translational research and collaboration between basic scientists and clinical researchers, providing seed funding to test new, innovative ideas and facilitating future grant support.
Basic scientists and clinicians across the Faculty and affiliated research institutes teamed up to submit joint applications as co-PIs on specific research projects. Applications were evaluated by an expert committee and the top three applications were awarded $50,000, made up of matching funds from each partner: the basic science department or research institute supporting PhD Scientists, and the clinical department supporting Clinician Scientists.
Congratulations to the recipients of the three grants awarded in the 2023 competition:
- Jing Wang (OHRI / Department of Cellular and Molecular Medicine (CMM)) and Eve Tsai (Department of Surgery): Neural reprogramming potential of human pericytes
- Seung-Hwan Lee (Department of Biochemistry, Microbiology and Immunology) and Alissa Visram (Department of Medicine/Division of Hematology): Investigating the effect of soluble BCMA on anti-tumor activity of BCMA targeted single domain chimeric antigen receptor NK cells in multiple myeloma
- Suresh Gadde (CMM) and Kevin Burns (Department of Medicine / Division of Nephrology): Bioengineered Nanoparticles to Prevent Acute Kidney Injury